Stalling on Mounjaro — why plateaus happen and what to do

The pattern

The classic Mounjaro weight loss curve looks something like this: a slow first month while the body adapts to the starter dose, accelerating loss through months 2–3 as you reach 5 mg or 7.5 mg, sustained loss through months 4–6, then a gradual flattening through months 6–12 as you approach a new metabolic baseline.

The flattening isn't 'Mounjaro stopping work'. It's the physiology of weight loss — the same curve you'd see on any successful intervention, just usually further along and bigger in magnitude. Understanding this changes how you respond to it.

The physiology, honestly

Three real things contribute to plateaus:

1. Reduced basal metabolic rate. As you lose weight, you have less body to maintain. A person who started at 110 kg and is now 90 kg burns meaningfully fewer calories at rest than they did at the start — a difference of perhaps 150–250 kcal/day. The calorie deficit that drove a 1 kg/week loss six months ago now only drives a 0.5 kg/week loss for the same intake.
2. Adaptive thermogenesis. Beyond the predictable drop in BMR, the body also subtly reduces non-exercise activity (NEAT) and metabolic efficiency in response to sustained energy deficit. This is a smaller effect than people often think — but it's real.
3. Behavioural drift. The hardest one to admit. Six months in, portion sizes creep back, snacking gradually returns, the pre-dinner glass of wine becomes two, the gym sessions become less frequent. None of these are dramatic enough to notice in isolation; together they neutralise a meaningful proportion of the original deficit.

These three together explain almost every plateau we see in clinic. The first is biological. The second is biological-ish. The third is behavioural — and it's the lever most patients can actually move.

Is it a real plateau or a stall?

Useful distinction:

• Short-term stall. 2–4 weeks of unchanged weight. Almost always due to water retention, glycogen replenishment, menstrual cycle effects, bowel content, or sodium variation. Resolves on its own. Don't change anything except consistency.
• True plateau. 8–12 weeks of no meaningful change on a stable, appropriate dose with consistent behaviour. Worth a structured review.

Three weeks of the scale not moving is not a plateau. It feels like one. It rarely is one.

The audit — what to actually check

Before anything else, do an honest 7–14 day audit of:

• Calorie intake. Most plateaus have calorie creep at the root. Track everything for a week. Not to be controlling — to be honest. Eat-outs, sauces, oils used in cooking, drinks, the spoonful from the kids' plates.
• Alcohol. See our alcohol guide. Liquid calories are the most under-reported. Two glasses of wine four nights a week is around 1,800 extra kcal/week, easily enough to flatten the curve.
• Protein. Inadequate protein during weight loss leaves you constantly mildly hungry and may slow the loss. Target 1.2–1.6 g/kg ideal body weight. See protein and resistance guide.
• Sleep. Sleep restriction (less than 6–7 hours) increases hunger hormones (ghrelin), reduces satiety hormones (leptin), and undermines food decisions the next day. If sleep has slipped, that's a plateau driver before anything else.
• Stress. Chronic stress drives cortisol, appetite, and reward-seeking behaviour. Major life stress in the previous 2–3 months often shows up as a plateau.
• Activity, especially NEAT. Step count drops are easy to miss. The walking commute that became a drive, the working-from-home day that became sedentary — they add up.
• Consistency. Have you been taking the medication on time, every week, at the dose you think you have? Missed doses, late doses, or quietly skipped weeks all matter.

If the audit reveals an obvious driver, fix that before changing dose. Most plateaus respond to a calibration like this within 3–6 weeks.

Tactical options if the audit is clean

If you've genuinely been consistent and the plateau is real and lasting 8–12+ weeks:

• Reduce daily intake by 200–300 kcal. Reflects the lower BMR at your new weight. Small protein-dense changes (a slightly smaller portion, an additional vegetable serving, a swap to lower-calorie alternatives) often do it without feeling restrictive.
• Add 1–2 resistance sessions per week. Preserves muscle, which keeps BMR higher and improves body composition independent of scale weight. See protein and resistance guide.
• Increase step count. NEAT is the largest variable component of daily energy expenditure. Adding 2,000–3,000 steps per day is meaningful.
• Consider a dose increase. If you're at 5 mg or 7.5 mg and you've been there for 12+ weeks with a true plateau, an increase to the next step (7.5 mg or 10 mg) may help. This is a clinical decision — not a self-titration.
• Consider a longer hold instead of an increase. Sometimes the body needs more time at the current dose, especially if side effects have been challenging or if you're close to a sensible maintenance weight.

When 'plateau' is actually the goal

If you've lost the weight you wanted to lose and you're settling at a sustainable new baseline — that's not a plateau, it's maintenance. The conversation shifts entirely.

Maintenance questions:

• What's the right ongoing dose? For many patients, this is a step down from peak dose rather than the maximum. The right maintenance is the lowest dose that holds weight stable with tolerable side effects.
• How long do you stay on it? GLP-1/GIP medication for chronic weight management is, on the evidence and the licence, an ongoing therapy. Stopping typically leads to gradual weight return. The structured programme should cover the maintenance conversation explicitly.
• What does the off-ramp look like if you do want to stop? Slow taper, monitoring, lifestyle scaffolding. See NHS Tier 3 vs private weight loss for relevant context on the 2-year NHS cap, which forces this conversation earlier for some patients.
• How do you keep this from being a yo-yo? The behaviour scaffolding that made loss possible is the same scaffolding that holds the result. The medication is one component, not the whole plan.

Weight isn't the only metric

When the scale stops moving but everything else is improving, take the win. Useful metrics besides scale weight:

• Waist circumference. Often falls when scale weight doesn't — fat loss with muscle preservation.
• Clothes fit. A simple, honest test.
• Body composition. If you have access to it (DEXA, bioimpedance), the ratio of fat to lean is more informative than scale weight alone.
• Fitness markers. Walking distance without breathlessness, stair climbing, resistance training progression.
• HbA1c, lipid profile, blood pressure. Metabolic improvements often continue at plateau.
• Sleep, mood, energy. Subjective but real.

Some patients hit plateau at a weight they're happy with and their objective health markers continue to improve over the following months. That's success, not failure.

When to suspect something else

If you've done the audit properly, kept consistent for 8–12+ weeks, optimised dose appropriately, and the plateau persists with no improvement in other markers, a few medical conditions are worth checking:

• Thyroid dysfunction. Both under- and overactive thyroid can affect weight regulation. A TSH and free T4 are simple to check.
• Perimenopause / menopause. Hormonal changes meaningfully alter metabolic response and body composition. A discussion with your GP about menopausal status — and whether HRT is appropriate — is worth having.
• New medications. Steroids, some antidepressants, some antipsychotics, beta blockers, and some diabetes medications can blunt weight loss response.
• Insulin resistance / metabolic syndrome. If not already assessed, a HbA1c, fasting insulin and lipid panel can identify undertreated metabolic features.
• PCOS. If you have PCOS and your insulin resistance isn't well-managed (or you've stopped metformin), the picture changes. See our PCOS guide.

How a structured programme helps with plateaus

The biggest advantage of pharmacist-led, in-person care over pen-only services shows up at plateau. A structured programme should include:

• A scheduled review when progress slows (not when you ask, but as a built-in checkpoint).
• A genuine behavioural audit, with someone external to your daily life looking at the data.
• The clinical judgement about whether dose change is appropriate — and the willingness to say 'not yet' or 'no'.
• The maintenance conversation when it's the right time.
• Connections to dietetic, psychological, or medical support when the picture is broader than weight alone.

If your current service is dispensing pens and isn't equipped to navigate plateaus, that's the moment a service-fit issue becomes a service-effectiveness issue.

The bigger picture

Plateaus are a normal, expected part of the weight loss curve, not a failure of the medication or of you. The best response is usually a calm review, an honest audit, and small calibrated changes — not a dramatic intervention. The patients who do best long-term are the ones who treat plateaus as a planned milestone in the programme rather than an emergency.

For context on what to expect across the full Mounjaro journey, see our Mounjaro explainer, side effects timeline, and Mounjaro vs Wegovy comparison.

The next step

If you're stuck on a plateau and want a structured review — audit, body composition discussion, dose conversation, the broader picture — a 30-minute consultation is the right next step. Bring your last 8 weeks of weight data (rough is fine), an honest account of intake, alcohol, sleep, activity, and any other changes in your life.